Managed Care

CareConnectMD Announces $25 Million Investment from TT Capital Partners to Fuel Expansion and Hiring

Retrieved on: 
Friday, August 5, 2022
Health, Professional Services, Nursing, Managed Care, Health Insurance, VBC, General number field sieve, Centers for Medicare & Medicaid Services, Community health, ACO, Patient, CEO, P.C, CMS, Population, Center, Industry, TTCP, Nursing, DCE, Palliative care, Contract, Investment, Technology, Communication, PacifiCare Health Systems, Quality of life, Accountable care organization, Partner, CCMD, Telehealth, Program, Global, Health insurance, Access, Medicare, Health, Professional Services, Nursing, Managed Care, Health Insurance

CareConnectMD will leverage the investment to deepen its presence in California, Ohio and Texas and expand into other marketsand to enhance its technology platform to scale and streamline care delivery.

Key Points: 
  • CareConnectMD will leverage the investment to deepen its presence in California, Ohio and Texas and expand into other marketsand to enhance its technology platform to scale and streamline care delivery.
  • The DCE model is a financial risk-sharing arrangement developed by CMS to reduce Medicare expenditures while enhancing the quality of care to members.
  • We are excited about the opportunities before us and thrilled to welcome TT Capital Partners as an investor and a partner.
  • TT Capital Partners (TTCP) is a value-add healthcare investor that provides capital, expertise and insight to healthcare technology and services companies that have the potential to become market leaders.

UK Care Market Report 2022: - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 5, 2022
Managed Care, Health, Other Health, Office for National Statistics, Human, News, Nursing, PDF, List of national and international statistical services, Health insurance

The "UK Care Markets (without digital archive)" newsletter has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "UK Care Markets (without digital archive)" newsletter has been added to ResearchAndMarkets.com's offering.
  • Care Markets delivers comprehensive, reliable and independent reporting on the full range of social care services being delivered across the UK.
  • The journal covers residential and nursing care, homecare, sheltered housing, extra care and assisted living for older people and adults with specialist care needs.
  • The publisher is the chosen provider of independent sector healthcare market data to the UK government's Office for National Statistics.

Two Cheshire NHS Trusts Select MEDITECH Expanse for Innovative Electronic Patient Record Plan

Retrieved on: 
Tuesday, July 5, 2022
Nursing, Health, Hospitals, Practice Management, Managed Care, General Health, Digital technology, Efficiency, England, NHS trust, DCS, ICB, Patient, LinkedIn, CEO, Trust, EPR, Adoption, Trust law, MEDITECH, Population, Goal, NHS England, Community, Woman, NHS, Certification, Hospital, Macclesfield District General Hospital, Victoria Infirmary, Cardigan and District Community Hospital, MID, Health, Â, East Cheshire NHS Trust, Solution, HIMSS, Leighton Hospital, Associate, Safety, Twitter, Multimedia, Interim, Mid Cheshire Hospitals NHS Foundation Trust, Facebook, Knutsford

Two NHS trusts in Cheshire today revealed plans to create a joint electronic patient record using MEDITECH Expanse .

Key Points: 
  • Two NHS trusts in Cheshire today revealed plans to create a joint electronic patient record using MEDITECH Expanse .
  • View the full release here: https://www.businesswire.com/news/home/20220705005134/en/
    East Cheshire NHS Trust and Mid Cheshire Hospitals NHS Foundation Trust sign for MEDITECH Expanse.
  • Id like to congratulate our colleagues at Mid Cheshire Hospitals NHS Foundation Trust and East Cheshire NHS Trust on taking the next step towards implementing their electronic patient record (EPR) systems, said Cathy Fox, NHS Cheshire and Merseyside Integrated Care Board (ICB) Associate Director of Digital Operations.
  • Following a detailed procurement process, MEDITECH was then chosen to supply East and Mid Cheshires electronic patient record, which was later approved by NHS England and Improvement.

Positive Results of EfficAPSI Real-World Study Confirm Significant Benefit of Sublingual Liquid AIT Treatment on the Onset and Worsening of Asthma in Patients With Allergic Rhinitis

Retrieved on: 
Saturday, July 2, 2022
Biotechnology, Health, Pharmaceutical, Clinical Trials, Managed Care, Diagnosis, LEN, Knowledge, Patient, Allergy, III, Agache, Czech Republic, ARIA, Nose, HDR, Itchy, Nasal congestion, AIT, EAACI, Paris Diderot University, Allergen, The Journal of Allergy and Clinical Immunology, Shyam Swarup Agarwal, Internal medicine, Allergic rhinitis, Disease, Sneeze, Public health, Water, Atopy, Profile, World, Risk, European Academy of Allergy and Clinical Immunology, MITES, World Health Organization, Doctor of Philosophy, Pulmonology, Time, House, Congress, Pharmacy, MD, Therapy, Pharmaceutical industry, Perfume, Asthma

Presented at the 2022 European Academy of Allergy and Clinical Immunology (EAACI) congress in Prague (Czech Republic), the real-world study confirmed significant benefit of sublingual liquid allergen immunotherapy treatment (AIT) on the onset and worsening of asthma in patients with allergic rhinitis.

Key Points: 
  • Presented at the 2022 European Academy of Allergy and Clinical Immunology (EAACI) congress in Prague (Czech Republic), the real-world study confirmed significant benefit of sublingual liquid allergen immunotherapy treatment (AIT) on the onset and worsening of asthma in patients with allergic rhinitis.
  • The primary objective of the study was the evaluation of the impact of sublingual liquid AIT on the onset and worsening of asthma in patients with allergic rhinitis.
  • The results of the EfficAPSI real-world study confirm and broaden the findings of randomised clinical trials and strengthen the body of evidence of the positive impact of sublingual liquid AIT on the onset and worsening of allergic asthma in patients with allergic rhinitis.
  • Its objective is to evaluate the real life impact of sublingual liquid allergen immunotherapy on the onset and worsening of asthma in patients with allergic rhinitis.

LTC Declares Its Monthly Common Stock Cash Dividend for the Third Quarter Of 2022

Retrieved on: 
Friday, July 1, 2022
Construction & Property, Nursing, Managed Care, Finance, Health, Professional Services, REIT, Residential Building & Real Estate, Annual report, LTC, Securities Act of 1933, Securities Exchange Act of 1934, REIT, Sale, Company, U.S. Securities and Exchange Commission, Housing, Investment, NYSE, Security (finance)

LTC Properties, Inc. (NYSE:LTC) announced today that it had declared a monthly cash dividend on its common stock for the third quarter of 2022.

Key Points: 
  • LTC Properties, Inc. (NYSE:LTC) announced today that it had declared a monthly cash dividend on its common stock for the third quarter of 2022.
  • The Company declared a monthly cash dividend of $0.19 per common share per month for the months of July, August and September 2022, payable on July 29, August 31 and September 30, 2022, respectively, to stockholders of record on July 21, August 23 and September 22, 2022, respectively.
  • LTC is a real estate investment trust (REIT) investing in seniors housing and health care properties primarily through sale-leasebacks, mortgage financing, joint-ventures and structured finance solutions, including preferred equity and mezzanine lending.
  • Based on its gross investments, LTCs investment portfolio is comprised of approximately 50% seniors housing and 50% skilled nursing properties.

CareTrust REIT Announces Changes to the Board of Directors

Retrieved on: 
Friday, July 1, 2022
REIT, Health, Construction & Property, Nursing, Managed Care, Acquisition, CEO, Church, Ownership, Nursing, Trust, Chairperson, NYSE, The Church of Jesus Christ of Latter-day Saints, Saint, Board, Leadership, Professional, Board of directors, Management

The Board of Directors of CareTrust REIT, Inc. (NYSE:CTRE) today announced the resignation of Greg Stapley as Executive Chair of the Companys Board of Directors.

Key Points: 
  • The Board of Directors of CareTrust REIT, Inc. (NYSE:CTRE) today announced the resignation of Greg Stapley as Executive Chair of the Companys Board of Directors.
  • Mr. Stapleys resignation from the Board follows his relinquishment of the Chief Executive role last January.
  • Speaking for the Board, were thrilled with how the CEO transition has taken place this year and are pleased to welcome Dave to the Board.
  • With the announced changes, CareTrusts Board continues to consist of five members, including Mr. Sedgwick.

Traumatic Brain Injury Assessment & Management Devices Market Report 2022-2026 - ResearchAndMarkets.com

Retrieved on: 
Friday, July 1, 2022
Managed Care, Health, Medical Devices, Acquisition, Traumatic brain injury, Partnership, Water management device

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years in Traumatic Brain Injury Assessment & Management Devices market.

Key Points: 
  • Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years in Traumatic Brain Injury Assessment & Management Devices market.
  • Key companies dominating the Global Traumatic Brain Injury Assessment & Management Devices Market.
  • Various opportunities available for the other competitor in the Traumatic Brain Injury Assessment & Management Devices Market space.
  • View source version on businesswire.com: https://www.businesswire.com/news/home/20220701005220/en/

Northwell Joins Healthcare Climate Council, Signs President Biden’s Pledge to Reduce Emissions

Retrieved on: 
Thursday, June 30, 2022
Climate Change, Practice Management, Environmental Policy, Managed Care, White House, Federal Government, Health, Environmental Issues, Hospitals, Public Policy, Government, Environment, Sustainability, Health equity, LinkedIn, Patient, CEO, HHS, Signature, Climate change, White House, Feinstein Institute for Medical Research, Multimedia, Industry, Policy, Investment, Office of Inspector General, U.S. Department of Health and Human Services, White, Nursing, Human, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Carbon footprint, Medicine, Instagram, Twitter, Physician, Eye, Medical research, Environmental policy of the Joe Biden administration, Hospital, Renewable energy, Management, Northwell Health, Health, Facebook

Northwell Health announced today that it has joined the Healthcare Climate Council, and separately, New Yorks largest health system signed on the U.S. Department of Health and Human Services (HHS) Health Care Sector Pledge to reduce organizational emissions.

Key Points: 
  • Northwell Health announced today that it has joined the Healthcare Climate Council, and separately, New Yorks largest health system signed on the U.S. Department of Health and Human Services (HHS) Health Care Sector Pledge to reduce organizational emissions.
  • Northwell has committed to meet the Biden administrations climate goal to reduce emissions 50 percent by 2030 and achieve net zero emissions by 2050.
  • Northwell Health has pledged to root out health disparities of all types and that includes addressing our own impacts on the climate.
  • The HHS Office of Climate Change and Health Equity developed the health sector climate pledge in conjunction with the White House to help focus the health care sectors response to climate change.

Tevogen Bio Establishes Philadelphia R&D Center to Expedite Product Development in Oncology, Neurology, and Virology

Retrieved on: 
Thursday, June 30, 2022
Neurology, Surgery, Other Health, Other Science, Pharmaceutical, Research, Oncology, Mental Health, Medical Devices, Infectious Diseases, Hospitals, Genetics, Fitness & Nutrition, Clinical Trials, Cardiology, Stem Cells, Science, Biotechnology, Practice Management, Nursing, Managed Care, Medical Supplies, AIDS, General Health, FDA, Health, Diabetes, Thomas Jefferson University Hospital, Cell, Malignancy, Patient, Bio, Korea Carbon Capture & Sequestration R&D Center, Research, State Farm Research and Development Center, Laboratory, COVID-19, Company, Degenerative disease, Terminology, Development, Toxic shock syndrome, Virology, CRS, CIC, Neurology, Cancer, Clinical trial, Center, Cytokine release syndrome, Virus, CTL, Medicine, Wanamaker, The Center, Multimedia, Forward-looking statement, Vaccine, Fine chemical

View the full release here: https://www.businesswire.com/news/home/20220630005760/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220630005760/en/
    Tevogen Bio establishes R&D Center in Philadelphias Wanamaker Office Building to expedite product development in oncology, neurology, and virology.
  • (Photo: Business Wire)
    The Center will serve as the central location for the companys product development initiatives and will house Tevogens Global R&D Leadership Team.
  • The Wanamaker location accompanies Tevogens recently announced CIC Philadelphia facilities which will provide the company with comprehensive research and product development capability.
  • The companys lead product, TVGN-489, is currently in clinical trial for high-risk COVID-19 patients at Jefferson University Hospitals in Philadelphia.

Carolyn Ingram Appointed Plan President of Molina Healthcare of New Mexico

Retrieved on: 
Thursday, June 30, 2022
Professional Services, Health, Insurance, Health Insurance, Managed Care, General Health, Puget Sound, Medicaid, Company, Sound, History, New Mexican, SCHIP, MBA, University, EVP, Â, Health insurance marketplace, Molina Healthcare, New Mexico State University, Medicare, Program, Health insurance, Management

Ingram also previously served as SCHIP director and chair of the New Mexico Medical Insurance Pool.

Key Points: 
  • Ingram also previously served as SCHIP director and chair of the New Mexico Medical Insurance Pool.
  • Carolyn has a deep understanding of New Mexicos needs and a proven history of successfully serving New Mexicans, said Marc Russo, EVP of health plans for Molina Healthcare.
  • Ingram joined Molina Healthcare in 2015 and has served in numerous national leadership positions, including executive vice president and chief marketing officer of Molina Healthcare and executive director of the MolinaCares Accord, which drives Molinas nationwide program to reduce racial disparities in health care.
  • Molina Healthcare of New Mexico has been providing government-funded, quality health care since 1998.